Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tocopharm is a specialized pharmaceutical company focused on the research, development, and manufacturing of high-purity pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialty excipients. The company is particularly recognized for its expertise in vitamin E derivatives, such as D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS), which is widely used as a solubilizer and absorption enhancer in drug delivery systems. Based in Hangzhou, China, Tocopharm provides contract research and manufacturing services (CRO/CMO) to global pharmaceutical and biotech firms, supporting the development of complex formulations and lipid-based drug delivery technologies. Their product portfolio also includes PEG derivatives and other specialty chemicals tailored for the life sciences industry. The company maintains high-quality standards and provides technical support for formulation challenges, helping clients improve the bioavailability of poorly soluble drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tocopharm.